Another Study Ties Pioglitazone to Bladder Cancer Risk (CME/CE)

(MedPage Today) -- Risk emerged within first 2 years; attenuated after discontinuing
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news